Study of Valortim® (MDX-1303) and Its Selected Formulation Components Percutaneous Use

NCT01204866 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Reactions

Interventions

BIOLOGICAL: Valortim and selected Components
DRUG: Valortim and Selected Components

Sponsor

PharmAthene, Inc.

Collaborators

[object Object]
[object Object]